# EDGAR Filing Document

**Accession Number:** 0001340243
**File Stem:** 0001628280-23-008967
**Filing Date:** 2023-3
**Character Count:** 3842
**Document Hash:** 7b90a53498fc37b8c557cb0a8c909fa1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-23-008967.hdr.sgml**: 20230323

**ACCESSION NUMBER**: 0001628280-23-008967

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 19

**CONFORMED PERIOD OF REPORT**: 20230323

**FILED AS OF DATE**: 20230323

**DATE AS OF CHANGE**: 20230323

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MorphoSys AG
- **CENTRAL INDEX KEY:** 0001340243
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** 2M
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38455
- **FILM NUMBER:** 23755006

**BUSINESS ADDRESS:**
- **STREET 1:** SEMMELWEISSTR. 7
- **CITY:** PLANEGG
- **STATE:** 2M
- **ZIP:** 82152
- **BUSINESS PHONE:** 49 89 89927-0

**MAIL ADDRESS:**
- **STREET 1:** SEMMELWEISSTR. 7
- **CITY:** PLANEGG
- **STATE:** 2M
- **ZIP:** 82152

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MORPHOSYS AG
- **DATE OF NAME CHANGE:** 20050929

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

**For the month of March, 2023**

**COMMISSION FILE NUMBER 001-38455**

**MorphoSys AG**

**Semmelweisstrasse 7**

**82152 Planegg**

**Germany**

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F: Form 20-F ⌧ Form 40-F ◻

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ◻

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ◻

------

On March 23, 2023, MorphoSys AG (the "Company") published two notifications of major holdings from The Goldman Sachs Group, Inc.

**<u>Exhibits</u>**

99.1&nbsp;&nbsp;&nbsp;&nbsp;<u>[Notification of Major Holdings from The Goldman Sachs Group, Inc.](a230323_exhibit991.htm)</u>

99.2&nbsp;&nbsp;&nbsp;&nbsp;<u>[Notification of Major Holdings from The Goldman Sachs Group, Inc.](a230323_exhibit992.htm)</u>

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

**&nbsp;&nbsp;&nbsp;&nbsp;**MORPHOSYS AG (Registrant)

Date: March 23, 2023&nbsp;&nbsp;&nbsp;&nbsp;By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ i.A. Robert Mayer</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Robert Mayer

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title:&nbsp;&nbsp;&nbsp;&nbsp;Director Investor Relations

&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ i.A. Kristina Grötsch&nbsp;&nbsp;&nbsp;&nbsp;</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Kristina Grötsch

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title:&nbsp;&nbsp;&nbsp;&nbsp;Senior Specialist Investor Relations &nbsp;&nbsp;&nbsp;&nbsp;

## Exhibit 99.1

![](a230323_exhibit991001.jpg)

------

![](a230323_exhibit991002.jpg)

------

![](a230323_exhibit991003.jpg)

------

![](a230323_exhibit991004.jpg)

------

![](a230323_exhibit991005.jpg)

------

![](a230323_exhibit991006.jpg)

------

![](a230323_exhibit991007.jpg)

------

![](a230323_exhibit991008.jpg)

------

## Exhibit 99.2

![](a230323_exhibit992001.jpg)

------

![](a230323_exhibit992002.jpg)

------

![](a230323_exhibit992003.jpg)

------

![](a230323_exhibit992004.jpg)

------

![](a230323_exhibit992005.jpg)

------

![](a230323_exhibit992006.jpg)

------

![](a230323_exhibit992007.jpg)

------

![](a230323_exhibit992008.jpg)

------